Improving prostate cancer care for US veterans
Official title: Optimizing Advanced Prostate Cancer Care Among US Veterans
Funded at Veterans Health Administration · NIH-10883551 · Data updated 2026-11-12
This study is looking to help Vietnam Veterans with metastatic prostate cancer by figuring out what makes it hard for them to get the best care and how their treatment experience can be improved.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| NIH project number | 5I01HX003687-02 |
| Project ID | NIH-10883551 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Vietnam Veterans, particularly those diagnosed with metastatic prostate cancer, especially Black men and those exposed to Agent Orange.
✕Less likely to help
Patients who are not Veterans or those without a diagnosis of metastatic prostate cancer may not benefit from this research.
What this research studies
This research focuses on understanding and improving the care provided to Vietnam Veterans diagnosed with metastatic prostate cancer, particularly addressing the unique challenges they face. It aims to identify barriers to receiving guideline-concordant care and assess the safety and overall experience of Veterans undergoing treatment. By utilizing an innovative natural language processing tool, the study will rapidly gather data on these patients to inform future interventions that personalize and enhance their treatment options.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better health outcomes for Veterans with metastatic prostate cancer.
How similar studies have gone: Other research has shown success in improving cancer care delivery through targeted interventions, making this approach promising yet tailored to the unique needs of Veterans.
Where this research is happening
-
Veterans Health Administration
Ann Arbor, United States Active
Researchers
- Principal investigator: Caram, Megan Elizabeth Veresh — Veterans Health Administration
- Study coordinator: Caram, Megan Elizabeth Veresh
Related research
Other NIH-funded projects on the same topics.
-
Drug that blocks tumor-made male hormones and the androgen receptor for advanced prostate cancer
A new medicine aims to block both the androgen receptor and the tumor’s own production of male hormones to help men with advanced, treatment‑resistant prostate cancer.
-
Boosting a tumor-suppressing enzyme to fight advanced prostate cancer
A research grant aims to develop new molecules that enhance the PP2A enzyme to slow or stop progression of advanced prostate cancer.
-
Modulating Androgen Signals to Boost CAR T Therapy for Prostate Cancer
A new approach uses CAR T cells targeting STEAP1 to treat advanced prostate cancer, with a focus on how androgen signals affect treatment effectiveness.
-
Genomic clues to guide therapy in advanced prostate cancer
This grant looks at how a patient’s tumor and germline DNA could predict which targeted or immune therapies will work best for advanced prostate cancer.
-
DACH1-based test to predict therapy response in advanced prostate cancer
A new test using DACH1 and other markers on prostate cancer tissue aims to predict which patients will respond to therapy and guide clinical trials.
-
Understanding how doctors choose treatments to improve advanced prostate cancer care
A clinician-researcher at Duke is exploring how medical decisions are made in advanced prostate cancer to help patients get better, fairer care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.